Response and Resistance to MEK Inhibition in Leukaemias Initiated by Hyperactive Ras

The Raf/MEK/ERK cascade is a therapeutic target in human cancers with deregulated Ras signaling, which includes tumours that have inactivated the Nf1 tumour suppressor(1). Nf1 encodes neurofibromin, a GTPase activating protein that terminates Ras signalling by stimulating hydrolysis of Ras•GTP. We c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lauchle, Jennifer O., Kim, Doris, Le, Doan T., Akagi, Keiko, Crone, Michael, Krisman, Kimberly, Warner, Kegan, Bonifas, Jeannette M., Li, Qing, Coakley, Kristin M., Diaz-Flores, Ernesto, Gorman, Matthew, Przybranowski, Sally, Tran, Mary, Kogan, Scott C., Roose, Jeroen P., Copeland, Neal, Jenkins, Nancy, Parada, Luis, Wolff, Linda, Sebolt-Leopold, Judith, Shannon, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119783/
https://www.ncbi.nlm.nih.gov/pubmed/19727076
http://dx.doi.org/10.1038/nature08279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119783/
https://www.ncbi.nlm.nih.gov/pubmed/19727076
http://dx.doi.org/10.1038/nature08279

Ejemplares similares